Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuen-Yi Tseng

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
ACS Nano|October 29, 2025
Alternating Electrochemical Redox-Cycling on Nanocomposite Biointerface for High-Efficiency Enzyme-Free Cell DetachmentCaroline McCue, Wang Hee Lee, Bert Vandereydt, et al.
Nature Genetics|October 10, 2017
Patient-derived xenografts undergo mouse-specific tumor evolutionUri Ben-David, Gavin Ha, Yuen-Yi Tseng, et al.
Nature Communications|March 26, 2022
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicityJulia Joung, Paul C Kirchgatterer, Ankita Singh, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Nature|August 10, 2017
Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhoodJulia Joung, Jesse M Engreitz, Silvana Konermann, et al.
Nature|September 22, 2017
Erratum: Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhoodJulia Joung, Jesse M Engreitz, Silvana Konermann, et al.
Nature|July 22, 2014
PVT1 dependence in cancer with MYC copy-number increaseYuen-Yi Tseng, Branden S Moriarity, Wuming Gong, et al.
The Journal of Clinical Investigation|February 27, 2025
Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Plos Genetics|August 6, 2016
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma DevelopmentKrinio Giannikou, Izabela A Malinowska, Trevor J Pugh, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
ACS Nano|October 29, 2025
Alternating Electrochemical Redox-Cycling on Nanocomposite Biointerface for High-Efficiency Enzyme-Free Cell DetachmentCaroline McCue, Wang Hee Lee, Bert Vandereydt, et al.
Nature Genetics|October 10, 2017
Patient-derived xenografts undergo mouse-specific tumor evolutionUri Ben-David, Gavin Ha, Yuen-Yi Tseng, et al.
Nature Communications|March 26, 2022
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicityJulia Joung, Paul C Kirchgatterer, Ankita Singh, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Nature|August 10, 2017
Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhoodJulia Joung, Jesse M Engreitz, Silvana Konermann, et al.
Nature|September 22, 2017
Erratum: Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhoodJulia Joung, Jesse M Engreitz, Silvana Konermann, et al.
Nature|July 22, 2014
PVT1 dependence in cancer with MYC copy-number increaseYuen-Yi Tseng, Branden S Moriarity, Wuming Gong, et al.
The Journal of Clinical Investigation|February 27, 2025
Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Plos Genetics|August 6, 2016
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma DevelopmentKrinio Giannikou, Izabela A Malinowska, Trevor J Pugh, et al.
Pageof 4